Search results
Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.
- Investor Relations Overview - Moderna
At Moderna, we promise to treat your data with respect and...
- Moderna Advances Multiple Vaccine Programs to Late-Stage ...
Moderna is also working with health authorities to align the...
- Moderna Achieves Positive Interim Results from Phase 3 Trial ...
Moderna Achieves Positive Interim Results from Phase 3 Trial...
- Our Story - Moderna
Moderna initiates first-in-human dosing for mRNA-1653, a...
- Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
In June 2023, the U.S. FDA advised that COVID-19 vaccines...
- Investor Relations Overview - Moderna
Sep 20, 2023 · Moderna COVID-19 Vaccine (2023-2024 Formula) Authorized For Individuals 6 Months through 11 Years of Age. On September 11, 2023, the Food and Drug Administration amended the emergency use ...
Moderna, Inc. (/ m ə ˈ d ɜːr n ə / mə-DUR-nə) is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response .
